Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/130362
Campo DC Valoridioma
dc.contributor.authorGómez-Acebo, Inésen_US
dc.contributor.authorDierssen-Sotos, Trinidaden_US
dc.contributor.authorDe Pedro, Maríaen_US
dc.contributor.authorPérez-Gómez, Beatrizen_US
dc.contributor.authorCastaño-Vinyals, Gemmaen_US
dc.contributor.authorFernández-Villa, Taniaen_US
dc.contributor.authorPalazuelos-Calderón, Camiloen_US
dc.contributor.authorAmiano, Pilaren_US
dc.contributor.authorEtxeberria, Jaioneen_US
dc.contributor.authorBenavente, Yolandaen_US
dc.contributor.authorFernández-Tardón, Guillermoen_US
dc.contributor.authorSalcedo-Bellido, Inmaculadaen_US
dc.contributor.authorCapelo, Rocíoen_US
dc.contributor.authorPeiró, Rosanaen_US
dc.contributor.authorMarcos-Gragera, Rafaelen_US
dc.contributor.authorHuerta, José M.en_US
dc.contributor.authorTardón, Adoninaen_US
dc.contributor.authorBarricarte, Aurelioen_US
dc.contributor.authorAltzibar, Jone Mirenen_US
dc.contributor.authorAlonso-Molero, Jessicaen_US
dc.contributor.authorDávila Batista, Verónicaen_US
dc.contributor.authorAragonés, Nuriaen_US
dc.contributor.authorPollán, Marinaen_US
dc.contributor.authorKogevinas, Manolisen_US
dc.contributor.authorLlorca, Javieren_US
dc.date.accessioned2024-05-13T14:05:44Z-
dc.date.available2024-05-13T14:05:44Z-
dc.date.issued2018en_US
dc.identifier.issn1471-2458en_US
dc.identifier.urihttp://hdl.handle.net/10553/130362-
dc.description.abstractBackground: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used despite their risk of gastrointestinal bleeding or cardiovascular events. We report the profile of people taking NSAIDs in Spain, and we include demographic factors, health-related behaviours and cardiovascular disease history. Methods: Four thousand sixtyparticipants were selected using a pseudorandom number list from Family Practice lists in 12 Spanish provinces. They completed a face-to-face computerized interview on their NSAID consumption, demographic characteristics, body mass index, alcohol and tobacco consumption and medical history. In addition, participants completed a self-administered food-frequency and alcohol consumption questionnaire. Factors associated with ever and current NSAID consumption were identified by logistic regression. Results: Women consumed more non-aspirin NSAIDs (38.8% [36.7-41.0]) than men (22.3 [20.5-24.2]), but men consumed more aspirin (11.7% [10.3-13.2]) than women (5.2% [4.3-6.3]). Consumption of non-aspirin NSAIDs decrease with age from 44.2% (39.4-49.1) in younger than 45 to 21.1% (18.3-24.2) in older than 75, but the age-pattern for aspirin usage was the opposite. Aspirin was reported by about 11% patients, as being twice as used in men (11.7%) than in women (5.2%); its consumption increased with age from 1.7% (< 45 years old) to 12.4% (≥75 years old). Aspirin was strongly associated with the presence of cardiovascular risk factors or established cardiovascular disease, reaching odds ratios of 15.2 (7.4-31.2) in women with acute coronary syndrome, 13.3 (6.2-28.3) in women with strokes and 11.1 (7.8-15.9) in men with acute coronary syndrome. Participants with cardiovascular risk factors or diseases consumed as much non-aspirin NSAID as participants without such conditions. Conclusions: Non-aspirin NSAIDs were more consumed by women and aspirin by men. The age patterns of aspirin and non-aspirin NSAIDs were opposite: the higher the age, the lower the non-aspirin NSAIDs usage and the higher the aspirin consumption. People with cardiovascular risk factors or diseases consumed more aspirin, but they did not decrease their non-aspirin NSAIDs usage.en_US
dc.languageengen_US
dc.relation.ispartofBMC Public Healthen_US
dc.sourceBMC Public Health [1471-2458], v. 18 (septiembre 2018)en_US
dc.subject32 Ciencias médicasen_US
dc.subject3212 Salud públicaen_US
dc.subject3202 Epidemologiaen_US
dc.subject.otherAspirinen_US
dc.subject.otherCardiovascular risken_US
dc.subject.otherGastrointestinal bleedingen_US
dc.subject.otherNon-steroidal anti-inflammatory drugsen_US
dc.subject.otherPropionatesen_US
dc.titleEpidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain studyen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1186/s12889-018-6019-zen_US
dc.identifier.pmid30241493-
dc.identifier.scopus2-s2.0-85053607687-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.identifier.issue1-
dc.relation.volume18en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.numberofpages13en_US
dc.utils.revisionen_US
dc.date.coverdateSeptiembre 2018en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr1,382
dc.description.jcr2,567
dc.description.sjrqQ1
dc.description.jcrqQ2
dc.description.scieSCIE
item.grantfulltextopen-
item.fulltextCon texto completo-
crisitem.author.deptGIR IUIBS: Diabetes y endocrinología aplicada-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.orcid0000-0001-8888-395X-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameDávila Batista, Verónica-
Colección:Artículos
Adobe PDF (933,04 kB)
Vista resumida

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.